SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹48,497 Cr | ₹43,886 Cr | ₹38,654 Cr | ₹33,498 Cr | ₹32,838 Cr |
What is the latest Revenue of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Revenue |
---|---|
Mar2024 | ₹48,497 Cr |
Mar2023 | ₹43,886 Cr |
Mar2022 | ₹38,654 Cr |
Mar2021 | ₹33,498 Cr |
Mar2020 | ₹32,838 Cr |
How is Revenue of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹48,497 Cr | 10.51 | |
Mar2023 | ₹43,886 Cr | 13.53 | |
Mar2022 | ₹38,654 Cr | 15.39 | |
Mar2021 | ₹33,498 Cr | 2.01 | |
Mar2020 | ₹32,838 Cr | - |
Compare Revenue of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹395,320.7 Cr | -2.3% | -3.5% | 9.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,562.0 Cr | -2.8% | 1.3% | 42.3% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -0.3% | 3% | -2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,558.0 Cr | -3.7% | 7.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,204.0 Cr | -1% | -0.5% | 13.2% | Stock Analytics | |
MANKIND PHARMA | ₹97,164.6 Cr | -1.4% | -7.7% | 5% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% |
-3.5% |
9.2% |
SENSEX | -1.3% |
-0.8% |
6.3% |
You may also like the below Video Courses